In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

RiboTargets closes $47mm private round

Executive Summary

RiboTargets (anti-infectives and oncology drugs) completed a third round private placement, selling $47mm (UK32mm) of its equity to lead participant JP Morgan and OrbiMed Advisors (both new investors) and returning investors Apax Partners, 3i PLC, Advent Venture Partners, NIB Capital, and Quester.

Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Molecular Diversity
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies